(Q34213109)

English

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

0 references

hospitalization

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

Toshifumi Hibi

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Takayuki Matsumoto

6

object named as

Takayuki Matsumoto

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Haruhiko Ogata

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jun Kato

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Fumihito Hirai

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nobuyuki Hida

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Toshiyuki Matsui

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Katsuyoshi Koyanagi

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

803-808

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21853

21 January 2018

Identifiers

10.1002/IBD.21853

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34213109&oldid=1954915398"